MedPath
HSA Product

DEXTROSE 5% AND SODIUM CHLORIDE 0.45% INJECTION USP

Product approved by Health Sciences Authority (SG)

Basic Information

DEXTROSE 5% AND SODIUM CHLORIDE 0.45% INJECTION USP

INJECTION

Regulatory Information

SIN05729P

April 8, 1991

General Sale List

Therapeutic

INTRAVENOUS

August 10, 2023

May 30, 2025

XB05XA03

Company Information

BAXTER HEALTHCARE (ASIA) PTE LTD

BAXTER HEALTHCARE (ASIA) PTE LTD

Active Ingredients

© Copyright 2025. All Rights Reserved by MedPath